Dice Therapeutics IncNASDAQ:DICE
- LAST PRICE31.7700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots29.7700/ 1
- Ask / Lots33.8000/ 1
- Open / Previous Close31.9700 / 31.7700
- Day Range
- 52 Week Range
- Volume241,525
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DICE |
|---|---|---|
| 09:32 ET | 2209 | 32.335 |
| 09:35 ET | 300 | 32.34 |
| 09:42 ET | 200 | 32.57 |
| 09:46 ET | 300 | 32.72 |
| 09:48 ET | 800 | 32.23 |
| 09:50 ET | 1924 | 32.29 |
| 09:51 ET | 100 | 32.45 |
| 09:53 ET | 400 | 32.25 |
| 09:55 ET | 400 | 32.26 |
| 09:57 ET | 100 | 32.5374 |
| 10:00 ET | 500 | 32.39 |
| 10:02 ET | 891 | 32.14 |
| 10:06 ET | 1574 | 32.31 |
| 10:08 ET | 700 | 32.31 |
| 10:09 ET | 100 | 32.25 |
| 10:11 ET | 200 | 32.12 |
| 10:13 ET | 354 | 32.17 |
| 10:15 ET | 688 | 32.2 |
| 10:18 ET | 500 | 32.3 |
| 10:20 ET | 400 | 32.31 |
| 10:22 ET | 100 | 32.42 |
| 10:24 ET | 200 | 32.37 |
| 10:26 ET | 1443 | 32.29 |
| 10:27 ET | 300 | 32.12 |
| 10:29 ET | 700 | 32.24 |
| 10:31 ET | 573 | 32.1 |
| 10:33 ET | 400 | 32.04 |
| 10:36 ET | 500 | 32 |
| 10:38 ET | 475 | 32 |
| 10:40 ET | 400 | 31.95 |
| 10:42 ET | 100 | 31.84 |
| 10:44 ET | 600 | 31.92 |
| 10:45 ET | 800 | 31.98 |
| 10:49 ET | 700 | 32 |
| 10:51 ET | 400 | 31.98 |
| 10:56 ET | 700 | 32.13 |
| 10:58 ET | 200 | 32.195 |
| 11:00 ET | 6766 | 32.39 |
| 11:02 ET | 6468 | 32.325 |
| 11:05 ET | 800 | 32.37 |
| 11:07 ET | 200 | 32.46 |
| 11:09 ET | 100 | 32.445 |
| 11:12 ET | 1000 | 32.25 |
| 11:18 ET | 411 | 32.19 |
| 11:20 ET | 1100 | 32 |
| 11:25 ET | 1550 | 31.92 |
| 11:27 ET | 400 | 32.025 |
| 11:34 ET | 7100 | 32.36 |
| 11:36 ET | 100 | 32.355 |
| 11:39 ET | 500 | 32.21 |
| 11:41 ET | 100 | 32.16 |
| 11:43 ET | 100 | 32.26 |
| 11:45 ET | 475 | 32.08 |
| 11:50 ET | 100 | 32.13 |
| 11:52 ET | 400 | 32.17 |
| 11:56 ET | 480 | 32.05 |
| 11:57 ET | 375 | 32.02 |
| 11:59 ET | 400 | 32.02 |
| 12:03 ET | 200 | 31.89 |
| 12:06 ET | 400 | 32.02 |
| 12:08 ET | 900 | 31.98 |
| 12:17 ET | 200 | 31.97 |
| 12:21 ET | 400 | 31.99 |
| 12:26 ET | 100 | 31.94 |
| 12:28 ET | 679 | 31.93 |
| 12:30 ET | 1300 | 31.945 |
| 12:33 ET | 200 | 31.9 |
| 12:37 ET | 1500 | 32.06 |
| 12:39 ET | 200 | 32.055 |
| 12:42 ET | 200 | 32.065 |
| 12:46 ET | 200 | 32.06 |
| 12:50 ET | 500 | 32.16 |
| 12:51 ET | 100 | 32.28 |
| 12:53 ET | 200 | 32.185 |
| 12:55 ET | 1600 | 32.03 |
| 12:57 ET | 300 | 31.97 |
| 01:08 ET | 365 | 31.87 |
| 01:09 ET | 300 | 31.94 |
| 01:11 ET | 100 | 31.9 |
| 01:18 ET | 600 | 31.91 |
| 01:20 ET | 100 | 31.95 |
| 01:22 ET | 200 | 31.92 |
| 01:24 ET | 200 | 31.9 |
| 01:26 ET | 200 | 31.9 |
| 01:27 ET | 100 | 31.905 |
| 01:31 ET | 800 | 32.015 |
| 01:36 ET | 100 | 31.99 |
| 01:38 ET | 462 | 31.98 |
| 01:40 ET | 100 | 31.91 |
| 01:44 ET | 100 | 31.86 |
| 01:49 ET | 500 | 31.87 |
| 01:51 ET | 200 | 31.905 |
| 01:56 ET | 100 | 31.86 |
| 01:58 ET | 200 | 31.83 |
| 02:00 ET | 100 | 31.88 |
| 02:02 ET | 800 | 31.87 |
| 02:03 ET | 1478 | 31.6517 |
| 02:07 ET | 100 | 31.75 |
| 02:09 ET | 400 | 31.66 |
| 02:12 ET | 600 | 31.63 |
| 02:16 ET | 300 | 31.56 |
| 02:20 ET | 600 | 31.43 |
| 02:23 ET | 400 | 31.53 |
| 02:27 ET | 400 | 31.545 |
| 02:30 ET | 300 | 31.51 |
| 02:36 ET | 646 | 31.475 |
| 02:38 ET | 200 | 31.44 |
| 02:41 ET | 500 | 31.475 |
| 02:43 ET | 200 | 31.475 |
| 02:48 ET | 800 | 31.53 |
| 02:50 ET | 100 | 31.51 |
| 02:52 ET | 1000 | 31.61 |
| 02:54 ET | 200 | 31.635 |
| 02:56 ET | 200 | 31.66 |
| 02:57 ET | 100 | 31.625 |
| 03:01 ET | 700 | 31.51 |
| 03:08 ET | 1097 | 31.45 |
| 03:10 ET | 100 | 31.485 |
| 03:12 ET | 700 | 31.48 |
| 03:14 ET | 700 | 31.52 |
| 03:15 ET | 300 | 31.525 |
| 03:17 ET | 100 | 31.54 |
| 03:19 ET | 700 | 31.67 |
| 03:21 ET | 1200 | 31.6 |
| 03:24 ET | 400 | 31.68 |
| 03:26 ET | 1841 | 31.7 |
| 03:28 ET | 500 | 31.66 |
| 03:30 ET | 100 | 31.63 |
| 03:32 ET | 272 | 31.67 |
| 03:33 ET | 1711 | 31.66 |
| 03:35 ET | 200 | 31.65 |
| 03:37 ET | 950 | 31.645 |
| 03:39 ET | 1000 | 31.605 |
| 03:42 ET | 7661 | 31.595 |
| 03:44 ET | 300 | 31.55 |
| 03:46 ET | 400 | 31.59 |
| 03:48 ET | 3579 | 31.58 |
| 03:50 ET | 400 | 31.505 |
| 03:51 ET | 1000 | 31.53 |
| 03:53 ET | 1300 | 31.56 |
| 03:55 ET | 3159 | 31.69 |
| 03:57 ET | 3366 | 31.79 |
| 04:00 ET | 5344 | 31.77 |
Jan 4, 2023
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference, from 4:05PM ET on Wednesday Jan 04, 2023 by GlobeNewswire
4:05PM ET on Wednesday Jan 04, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dice Therapeutics Inc | 1.5B | -15.5x | --- |
Immunitybio Inc | 1.5B | -3.8x | --- |
Replimune Group Inc | 1.5B | -10.2x | --- |
Rhythm Pharmaceuticals Inc | 1.5B | -7.6x | --- |
Viridian Therapeutics Inc | 1.5B | -8.7x | --- |
Arcellx Inc | 1.5B | -8.1x | --- |
Company Information
DICE Therapeutics, Inc., formerly Dice Molecules Holdings LLC, is a biopharmaceutical company. The Company leverages its technology platform to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It is focused on developing oral therapeutics against targets in immunology. The Company’s platform, which it refers to as DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. Its lead therapeutic candidate, DC-806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. The Company is also developing oral therapeutic candidates targeting α4ß7 integrin and αVß1/αVß6 integrin for the treatment of inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).
Contact Information
- Headquarters
- 279 E. Grand Avenue, Suite 300, Lobby BSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-566-1402
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Scheller
- Chief Executive Officer, Founder, Director
- J. Kevin Judice
- Chief Business and Chief Financial Officer
- Scott Robertson
- Chief Scientific Officer
- John Jacobsen
- Chief Medical Officer
- Timothy Lu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 47.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.05 |
Book Value | $8.19 |
P/E Ratio | -15.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
